Abstract Aims In this first interim analysis of the SCORE study, we investigated the risk of major adverse cardiovascular events (MACE) among individuals with atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity but without diabetes who initiated semaglutide 2.4 mg in real‐world settings.
Kim G. Smolderen +10 more
wiley +1 more source
Diagnostic yield of whole exome sequencing with targeted gene analysis in prelingual sensorineural hearing loss in Thailand. [PDF]
Damrongchietanon T +8 more
europepmc +1 more source
Different Distribution of HLA Class II Alleles According to Response to Corticosteroid Therapy in Sudden Sensorineural Hearing Loss [PDF]
Sang Won Yeo +6 more
openalex +1 more source
Hyperbaric oxygen therapy for sudden sensorineural hearing loss. [PDF]
Alam F +4 more
europepmc +1 more source
Deferoxamine Mesylate-Associated Sensorineural Hearing Loss
Hidetaka Kanno +3 more
openalex +2 more sources
Correlation of air pollution and risk of sudden sensorineural hearing loss: a Mendelian randomization study. [PDF]
Luo X +6 more
europepmc +1 more source
Improvement of Speech Recognition with Zero-Crossing in Patients with Sensorineural Hearing Loss.
Kôji Miyata +5 more
openalex +2 more sources
Sensorineural hearing loss and retinopathy in sickle cell patients. [PDF]
Ewusi-Wilson RK +3 more
europepmc +1 more source
Role of ginkgo biloba extract in acquired sensorineural hearing loss
Aman Kumar +2 more
openalex +2 more sources

